Johnson Investment Counsel’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43M | Sell |
3,679
-265
| -7% | -$112K | 0.01% | 403 |
|
|
2026
Q1 | $1.87M | Sell |
3,944
-490
| -11% | -$247K | 0.02% | 338 |
|
|
2025
Q4 | $2.07M | Sell |
4,434
-241
| -5% | -$112K | 0.02% | 307 |
|
|
2025
Q3 | $1.99M | Sell |
4,675
-139
| -3% | -$53.9K | 0.02% | 313 |
|
|
2025
Q2 | $1.84M | Sell |
4,814
-503
| -9% | -$181K | 0.02% | 318 |
|
|
2025
Q1 | $1.84M | Sell |
5,317
-30
| -0.6% | -$9.65K | 0.02% | 307 |
|
|
2024
Q4 | $1.6M | Sell |
5,347
-125
| -2% | -$43.7K | 0.02% | 322 |
|
|
2024
Q3 | $2.22M | Sell |
5,472
-71
| -1% | -$26K | 0.02% | 272 |
|
|
2024
Q2 | $1.78M | Buy |
5,543
+106
| +2% | +$34.4K | 0.02% | 285 |
|
|
2024
Q1 | $1.81M | Sell |
5,437
-67
| -1% | -$20.5K | 0.02% | 291 |
|
|
2023
Q4 | $1.49M | Sell |
5,504
-11
| -0.2% | -$2.72K | 0.02% | 308 |
|
|
2023
Q3 | $1.36M | Buy |
5,515
+450
| +9% | +$123K | 0.02% | 310 |
|
|
2023
Q2 | $1.54M | Sell |
5,065
-673
| -12% | -$187K | 0.02% | 299 |
|
|
2023
Q1 | $1.51M | Hold |
5,738
| – | – | 0.02% | 284 |
|
|
2022
Q4 | $1.38M | Buy |
5,738
+51
| +0.9% | +$11.4K | 0.02% | 299 |
|
|
2022
Q3 | $1.04M | Buy |
5,687
+10
| +0.2% | +$1.99K | 0.02% | 318 |
|
|
2022
Q2 | $954K | Buy |
5,677
+246
| +5% | +$52.8K | 0.01% | 336 |
|
|
2022
Q1 | $1.36M | Buy |
5,431
+10
| +0.2% | +$2.51K | 0.02% | 294 |
|
|
2021
Q4 | $1.39M | Buy |
5,421
+1,050
| +24% | +$257K | 0.02% | 301 |
|
|
2021
Q3 | $1.06M | Sell |
4,371
-151
| -3% | -$36.9K | 0.01% | 338 |
|
|
2021
Q2 | $935K | Buy |
4,522
+458
| +11% | +$93.3K | 0.01% | 339 |
|
|
2021
Q1 | $765K | Buy |
4,064
+34
| +0.8% | +$6K | 0.01% | 358 |
|
|
2020
Q4 | $663K | Buy |
4,030
+30
| +0.8% | +$4.39K | 0.01% | 363 |
|
|
2020
Q3 | $499K | Sell |
4,000
-23
| -0.6% | -$2.85K | 0.01% | 383 |
|
|
2020
Q2 | $390K | Sell |
4,023
-31
| -0.8% | -$3.22K | 0.01% | 426 |
|
|
2020
Q1 | $364K | Buy |
4,054
+129
| +3% | +$16.7K | 0.01% | 417 |
|
|
2019
Q4 | $580K | Sell |
3,925
-181
| -4% | -$24.3K | 0.01% | 393 |
|
|
2019
Q3 | $494K | Sell |
4,106
-50
| -1% | -$6.46K | 0.01% | 414 |
|
|
2019
Q2 | $561K | Buy |
4,156
+1,720
| +71% | +$217K | 0.01% | 405 |
|
|
2019
Q1 | $317K | Buy |
2,436
+36
| +2% | +$4.83K | 0.01% | 487 |
|
|
2018
Q4 | $298K | Buy |
2,400
+319
| +15% | +$42.8K | 0.01% | 481 |
|
|
2018
Q3 | $289K | Sell |
2,081
-28
| -1% | -$3.49K | 0.01% | 529 |
|
|
2018
Q2 | $216K | Buy |
+2,109
| New | +$213K | 0.01% | 586 |
|
Other funds holding HCA
Johnson Investment Counsel's HCA Position: Q2 2026 in Review
Johnson Investment Counsel reduced its HCA Healthcare (HCA) stake by 6.7% in Q2 2026, selling an estimated $112K and leaving 3,679 shares worth $1.43M. The position accounts for 0.01% of the portfolio, ranked #403.
Johnson Investment Counsel first reported a position in HCA in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.22M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Johnson Investment Counsel held 3,679 shares of HCA Healthcare worth $1.43M as of Q2 2026.
- Johnson Investment Counsel sold 265 HCA Healthcare shares in Q2 2026, an estimated $112K.
- HCA Healthcare made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #403 holding.
- Johnson Investment Counsel first reported a position in HCA Healthcare in Q2 2018 and has held it in 33 quarters since.
- Johnson Investment Counsel's HCA Healthcare position peaked at $2.22M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.